Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence

DOI: 10.4239/wjd.v10.i5.291

Keywords: Type 2 diabetes mellitus, Glucagon-like-peptide 1 agonists, Sodium-glucose cotransporter-2 inhibitor, Cardiovascular disease, Major adverse cardiovascular event

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text